Assessment of Circulating Matrix Metalloproteinase 9 (MMP-9) Levels in Non-invasive Diagnosis and Predicting Prognosis of Hepatocellular Carcinoma After Successful DAA Therapy of - Egyptian Knowledge Bank

418116

Assessment of Circulating Matrix Metalloproteinase 9 (MMP-9) Levels in Non-invasive Diagnosis and Predicting Prognosis of Hepatocellular Carcinoma After Successful DAA Therapy of

Article

Last updated: 29 Mar 2025

Overview Similar Items

Article

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Article

Diagnostic value of MMP-1 in chronic liver diseases

Article

Assessment of Von Willebrand Factor in Hepatitis C Patients as Biomarker for Liver Fibrosis and Predictor of HCC

Article

OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA

Article

Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs)

Article

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy

Article

Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma

Article

Assessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease

Article

Plasma albumin m RNA as anon invasive Marker to predict liver injury in chronic Hepatitis C and Hepatocellular carcinoma patients

Article

Expression of Matrix Metalloproteinase 1(MMP1) in HepatoCellular Carcinoma (HCC): Immunohistochemical and Biochemical Studies